Pain medication and dependence: when the prescription becomes the problem

The cultural script for opioid dependence involves street drugs, needles, and lives in visible disarray. It doesn't involve a repeat prescription from a GP, a pill box on the kitchen bench, and a person who works full-time and has never sought illicit drugs in their life.

But that second picture describes a significant and largely invisible portion of opioid dependence in Australia. Prescription opioid dependence , developing through legitimate pain management, surgical recovery, or the slow drift of ongoing prescribing , is common, underrecognised, and qualitatively different from the cultural image in ways that make it harder to see and harder to name.

The Australian context

Australia had a substantial increase in prescription opioid prescribing through the 2000s and 2010s, following international trends. The Penington Institute's Australia's Annual Overdose Report consistently shows pharmaceutical opioids , particularly oxycodone (OxyContin, Endone) and increasingly fentanyl patches , as the primary contributors to opioid overdose mortality in Australia, ahead of heroin.

The TGA's regulation of codeine to prescription-only in 2018 was a direct response to high levels of over-the-counter codeine-containing analgesic dependence, particularly Nurofen Plus and similar products. Many people who were dependent on these products had never used an illicit drug and didn't identify as having a substance use problem.

The medications most commonly involved in prescription opioid dependence in Australia include: - Oxycodone (OxyContin, Endone, Targin) - Tramadol (Tramal, Zydol) - Codeine (now prescription-only) - Fentanyl patches and lozenges - Hydromorphone (Dilaudid) - Tapentadol (Palexia)

How dependence develops

The pathway from pain management to dependence is gradual and often invisible until it is well established. Key stages:

Acute pain management is the starting point. An injury, a surgery, a dental procedure produces genuine, significant pain. Opioids are prescribed appropriately. They work. The pain resolves over weeks, the prescription continues, and the dose may be tapered , or may not.

Tolerance develops quietly. The dose that provided good pain relief at six weeks provides somewhat less relief at three months. This is a physiological certainty , opioid tolerance is well documented and nearly universal with regular use. The response, often, is dose escalation: a higher dose or more frequent administration. Each escalation normalises the new level and sets a new floor from which tolerance will again develop.

Pseudo-addiction is a clinical concept describing the pattern where undertreated pain produces behaviours , requesting dose increases, early prescription refills, preoccupation with medication , that look like addiction but reflect inadequately managed pain. Distinguishing pseudo-addiction from developing addiction requires careful clinical attention, and the distinction is often not made.

Physical dependence becomes established. The body's opioid receptors, chronically occupied, down-regulate their own sensitivity and reduce endogenous opioid production. When the medication is reduced or missed, withdrawal occurs: the well-described opioid withdrawal syndrome , sweating, goosebumps, insomnia, muscle aches, anxiety, nausea, diarrhoea. The motivation to continue using shifts from pain relief toward withdrawal avoidance, though the person experiencing this transition often doesn't frame it that way.

Hyperalgesia , paradoxical opioid-induced pain sensitisation , is a further complication in long-term opioid use. Some people find that their pain sensitivity has actually increased over time on opioids, meaning the medication prescribed for pain may be contributing to increased pain perception. The RACGP guidance on chronic pain management addresses this issue directly.

What it feels like from the inside

The experience of prescription opioid dependence is distinct from the cultural image in important ways.

There is often no euphoria to speak of, particularly in people who have been on opioids for an extended period. Tolerance to the euphoric effects develops faster than tolerance to the analgesic and dependence-producing effects. Many people dependent on prescription opioids report that the medication doesn't make them feel good , it makes them feel normal. The dose is required to function, to not feel sick, to get through the day.

The identity disruption can be profound. People who have not misused their medication, who took it as prescribed, who think of themselves as responsible and not as people with drug problems, find themselves in a situation that doesn't fit any category they have for themselves. The shame and confusion this produces often delays disclosure to GPs, and delays seeking help.

Functional impairment can be subtle and prolonged. Cognitive slowing, constipation, hormonal disruption (opioids suppress sex hormone production), social withdrawal, and emotional blunting are common effects of long-term opioid use that accumulate quietly and are attributed to other causes.

The options

Unlike methamphetamine dependence, prescription opioid dependence has well-established pharmacological treatment options. In Australia:

Opioid agonist treatment (OAT) , methadone or buprenorphine (Suboxone, Subutex) , is the most evidence-supported treatment for opioid dependence. It is not a substitute one addiction for another: OAT is an evidence-based medical treatment that stabilises physiology, eliminates withdrawal, reduces mortality risk, and allows the person to function. NDARC's evidence review documents outcomes that are substantially better than tapering without OAT for many patients.

Medically supervised tapering, for patients with lower-level dependence or strong preference, involves gradual dose reduction under medical supervision. This is most successful when the underlying pain condition is also being actively managed through non-opioid approaches.

Pain psychology and rehabilitation addresses the central sensitisation and psychological dimensions of chronic pain that opioids often mask rather than resolve.

The first step for most people is an honest conversation with a GP or a specialist addiction medicine physician. The Alcohol and Drug Foundation's directory and ADIS (for NSW) or equivalent state services can assist with finding appropriate support.

See also: you don't need a rock bottom to change your relationship with substances.

ayodee is an anonymous tool for tracking substance use, mood, and wellbeing. No email required. Free to start at ayodee.app.